Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date31 Jul 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient ustekinumab (ATC code according to WHO: L04AC05)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date28 Feb 2026
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient sultamicillin (ATC code according to WHO: J01CR04)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date31 Oct 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement. According to § 130a Para. 8 Sgb V by means of a so-called open-house model for the active substance pancreatin (ATC code according to Who: A09aa02) (132/2023-oh)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Aerospace and Defence
Germany
Closing Date31 Mar 2025
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Rivaroxaban (atc-code Nach Who: B01af01)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Closing Date31 Jan 2026
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient dimethyl fumarate (official ATC code: L04AX07)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Others
Germany
Closing Date31 Jan 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Dimethylfumarat (amtlicher Atc-code: L04ax07)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date31 May 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient interferon beta-1b (ATC code according to WHO: L03ab08)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date31 May 2025
Tender AmountRefer Documents 
Germany-erfurt: Pharmaceutical Products

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Closing Date31 Mar 2025
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Natalizumab (atc-code Nach Who: L04ag03)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Chemical Products
Germany
Closing Date31 Jan 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Oh-modells Zum Wirkstoff Fentanyl In Der Darreichungsform Lutschtabletten (lut) (atc-code Nach Who: N02ab03)
141-150 of 181 active Tenders